Glucose Transporter Type 1 (Glut1) Deficiency Syndrome Rare, But Treatable-Ketogenic Dietary Therapy as First-Line Therapy

被引:0
作者
Schonlaub, A. [1 ]
Holler, A. [2 ]
Karall, D. [3 ]
Klepper, J. [4 ]
Scholl-Burgi, S. [3 ]
机构
[1] Med Univ Innsbruck, Dept Kinder & Jugendheilkunde, Padiatrie 1, Neuropadiatrie, Innsbruck, Austria
[2] Ao Landeskrankenhaus Innsbruck, Univ Kliniken Innsbruck, Diatol Ernahrungsmed, Innsbruck, Austria
[3] Med Univ Innsbruck, Tirol Kliniken GmbH, Dept Kinder & Jugendheilkunde, Klin Padiatrie 1 Angeborene Stoffwechselstorungen, Anichstr 35, A-6020 Innsbruck, Austria
[4] Klinikum Aschaffenburg Alzenau, Klin Kinder & Jugendmed, Dept Padiatrie & Neuropadiatrie, Aschaffenburg, Germany
来源
PADIATRIE UND PADOLOGIE | 2022年 / 57卷 / 01期
关键词
Glucose-1 transporter defect; Refractory seizures; Ketogenic diet; Ketogenic dietary therapies; Movement disorders; GLUCOSE-TRANSPORTER-1; DEFICIENCY; SLC2A1; MUTATIONS; DIAGNOSIS; SEIZURES; ABSENCE;
D O I
10.1007/s00608-021-00958-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Glut1 Deficiency Syndrome (Glut1-DS) is a rare metabolic disease that leads to complex encephalopathy. This is due to heterozygous, de novo mutations in theSLC2A1 gene in the majority of cases. The absence or reduced function of glucose transporter type 1 (GLUT1) causes an energy deficiency of the central nervous system (CNS), as not enough glucose is transported across the blood-brain barrier. The disease usually becomes apparent through cerebral seizures (such as absences or myoclonic-astatic seizures) in infancy and early childhood. Characteristic initial symptoms of the disease are also paroxysmal eye-head movements in infants. There is usually a global developmental impairment with a complex cerebral movement disorder; its main components are ataxia, dystonia, spasticity, and dysarthria. Some of the most severely affected patients develop secondary microcephaly. Some symptoms improve after meals because of the postprandial increase in the level of blood glucose. Symptoms are age related-in infancy and early childhood epilepsy is dominant, in adolescents and adults it is cerebral movement disorders. Diagnosis is based on: 1. typical clinical signs; 2. decreased CSF glucose in the presence of normoglycaemia; and 3. detection of a pathogenic variant of SLC2A1 gene. When Glut1-DS is strongly suspected or diagnosed, therapy must be initiated immediately to reach optimal cognitive development. As the CNS can use ketone bodies as an alternative source of energy instead of glucose, ketogenic dietary therapies (KDTs) are the treatment of choice. In the KDTs (classical ketogenic diet, modified Atkins diet), ketogenesis is induced by a high-fat and low-carbohydrate diet. Depending on the age of the patient, the compliance of the patient and his family, and the efficacy of the KDT, either the classic ketogenic diet or the Atkins diet is applied to achieve sufficient ketosis. The KDT should be continued at least until early adulthood.
引用
收藏
页码:16 / 22
页数:7
相关论文
共 19 条
  • [11] Glut1 Deficiency Syndrome (Glut1DS): State of the art in 2020 and recommendations of the international Glut1DS study group
    Klepper, Joerg
    Akman, Cigdem
    Armeno, Marisa
    Auvin, Stephane
    Cervenka, Mackenzie
    Cross, Helen J.
    De Giorgis, Valentina
    Della Marina, Adela
    Engelstad, Kristin
    Heussinger, Nicole
    Kossoff, Eric H.
    Leen, Wilhelmina G.
    Leiendecker, Baerbel
    Monani, Umrao R.
    Oguni, Hirokazu
    Neal, Elizabeth
    Pascual, Juan M.
    Pearson, Toni S.
    Pons, Roser
    Scheffer, Ingrid E.
    Veggiotti, Pierangelo
    Willemsen, Michel
    Zuberi, Sameer M.
    De Vivo, Darryl C.
    [J]. EPILEPSIA OPEN, 2020, 5 (03) : 354 - 365
  • [12] Paroxysmal Nonepileptic Events in Glut1 Deficiency
    Klepper, Joerg
    Leiendecker, Baerbel
    Eltze, Christin
    Heussinger, Nicole
    [J]. MOVEMENT DISORDERS CLINICAL PRACTICE, 2016, 3 (06): : 607 - 610
  • [13] Absence of SLC2A1 Mutations Does Not Exclude Glut1 Deficiency Syndrome
    Klepper, Joerg
    [J]. NEUROPEDIATRICS, 2013, 44 (04) : 235 - 236
  • [14] The role of SLC2A1 mutations in myoclonic astatic epilepsy and absence epilepsy, and the estimated frequency of GLUT1 deficiency syndrome
    Larsen, Jan
    Johannesen, Katrine Marie
    Ek, Jakob
    Tang, Shan
    Marini, Carla
    Blichfeldt, Susanne
    Kibaek, Maria
    von Spiczak, Sarah
    Weckhuysen, Sarah
    Frangu, Mimoza
    Neubauer, Bernd Axel
    Uldall, Peter
    Striano, Pasquale
    Zara, Federico
    Kleiss, Rebecca
    Simpson, Michael
    Muhle, Hiltrud
    Nikanorova, Marina
    Jepsen, Birgit
    Tommerup, Niels
    Stephani, Ulrich
    Guerrini, Renzo
    Duno, Morten
    Hjalgrim, Helle
    Pal, Deb
    Helbig, Ingo
    Moller, Rikke Steensbjerre
    [J]. EPILEPSIA, 2015, 56 (12) : E203 - E208
  • [15] Child Neurology: Differential diagnosis of a low CSF glucose in children and young adults
    Leen, Wilhelmina G.
    de Wit, Cornelis J.
    Wevers, Ron A.
    van Engelen, Baziel G.
    Kamsteeg, Erik-Jan
    Klepper, Joerg
    Verbeek, Marcel M.
    Willemsen, Michel A.
    [J]. NEUROLOGY, 2013, 81 (24) : E178 - E181
  • [16] Cerebrospinal Fluid Glucose and Lactate: Age-Specific Reference Values and Implications for Clinical Practice
    Leen, Wilhelmina G.
    Willemsen, Michel A.
    Wevers, Ron A.
    Verbeek, Marcel M.
    [J]. PLOS ONE, 2012, 7 (08):
  • [17] Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder
    Leen, Wilhelmina G.
    Klepper, Joerg
    Verbeek, Marcel M.
    Leferink, Maike
    Hofste, Tom
    van Engelen, Baziel G.
    Wevers, Ron A.
    Arthur, Todd
    Bahi-Buisson, Nadia
    Ballhausen, Diana
    Bekhof, Jolita
    van Bogaert, Patrick
    Carrilho, Ines
    Chabrol, Brigitte
    Champion, Michael P.
    Coldwell, James
    Clayton, Peter
    Donner, Elizabeth
    Evangeliou, Athanasios
    Ebinger, Friedrich
    Farrell, Kevin
    Forsyth, Rob J.
    de Goede, Christian G. E. L.
    Gross, Stephanie
    Grunewald, Stephanie
    Holthausen, Hans
    Jayawant, Sandeep
    Lachlan, Katherine
    Laugel, Vincent
    Leppig, Kathy
    Lim, Ming J.
    Mancini, Grazia
    Della Marina, Adela
    Martorell, Loreto
    McMenamin, Joe
    Meuwissen, Marije E. C.
    Mundy, Helen
    Nilsson, Nils O.
    Panzer, Axel
    Poll-The, Bwee T.
    Rauscher, Christian
    Rouselle, Christophe M. R.
    Sandvig, Inger
    Scheffner, Thomas
    Sheridan, Eamonn
    Simpson, Neil
    Sykora, Parol
    Tomlinson, Richard
    Trounce, John
    Webb, David
    [J]. BRAIN, 2010, 133 : 655 - 670
  • [18] Phenotypic Spectrum of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
    Pearson, Toni S.
    Akman, Cigdem
    Hinton, Veronica J.
    Engelstad, Kristin
    De Vivo, Darryl C.
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (04)
  • [19] Wang D., 1993, GeneReviews